Showing results (131-140 of 148) with videos related to

Sort By:
Pageof 15
Psychiatry Research|September 25, 2018
Hypovitaminosis D is associated with depression and anxiety in schizophrenia: Results from the national FACE-SZ cohortG Fond, O Godin, F Schürhoff, et al.
Journal of Affective Disorders|August 4, 2020
Evolution and characteristics of the use of valproate in women of childbearing age with bipolar disorder: Results from the FACE-BD cohortL Samalin, O Godin, E Olié, et al.
Schizophrenia Research|May 23, 2016
Differential effects of childhood trauma and cannabis use disorders in patients suffering from schizophreniaG Baudin, O Godin, M Lajnef, et al.
European Archives of Psychiatry and Clinical Neuroscience|July 19, 2022
The impact of parent history of severe mental illness on schizophrenia outcomes: results from the real-world FACE-SZ cohortA Garosi, P L Sunhary de Verville, D Etchecopar-Etchart, et al.
Journal of Affective Disorders|July 16, 2020
Major depression, sleep, hostility and body mass index are associated with impaired quality of life in schizophrenia. Results from the FACE-SZ cohortG Fond, T Korchia, P L Sunhary de Verville, et al.
Journal of Affective Disorders|February 15, 2020
Adherence to treatment guidelines in clinical practice for using electroconvulsive therapy in major depressive episodeL Samalin, A Yrondi, T Charpeaud, et al.
European Archives of Psychiatry and Clinical Neuroscience|March 29, 2017
Benzodiazepine long-term administration is associated with impaired attention/working memory in schizophrenia: results from the national multicentre FACE-SZ data setGuillaume Fond, F Berna, L Boyer, et al.
Schizophrenia Research|September 11, 2017
Risk factors for increased duration of untreated psychosis. Results from the FACE-SZ datasetG Fond, L Boyer, M Andrianarisoa, et al.
Journal of Affective Disorders|December 18, 2015
Peripheral sub-inflammation is associated with antidepressant consumption in schizophrenia. Results from the multi-center FACE-SZ data setG Fond, O Godin, L Brunel, et al.
L'Encephale|August 21, 2017
[French Society for Biological Psychiatry and Neuropsychopharmacology and Fondation FondaMental task force: Formal Consensus for the management of treatment-resistant depression]T Charpeaud, J-B Genty, S Destouches, et al.
Pageof 15